TY  - JOUR

T1  - Rivaroxaban for Preventing Atherothrombotic Events in People with Acute Coronary Syndrome and Elevated Cardiac Biomarkers: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

JO  - PharmacoEconomics

UR  - http://eprints.whiterose.ac.uk/93179/

PY  - 2015/12/21

AU  - Pandor A

AU  - Pollard D

AU  - Chico T

AU  - Henderson R

AU  - Stevenson M

ED  - 

DO  - DOI: 10.1007/s40273-015-0351-2

PB  - Springer Science and Business Media LLC

VL  - 34

IS  - 5

SP  - 463

EP  - 477

Y2  - 2024/10/23

ER  -